Protective effect of low molecular fraction of MGN-3, a modified arabinoxylan from rice bran, on acute liver injury by inhibition of NF-κB and JNK/MAPK expression

International Immunopharmacology

Volumn 14, Issue 4, 2012, Pages 764-769

  Zheng, Surina ^a   Sugita, Shunsuke ^a   Hirai, Shizuka ^a   Egashira, Yukari ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

CD14; d Galactosamine; Hepatic injury; MAPK; Modified arabinoxylan; NF B

Indexed keywords

ALANINE AMINOTRANSFERASE; ARABINOXYLAN; ASPARTATE AMINOTRANSFERASE; CD14 ANTIGEN; GALACTOSAMINE; I KAPPA B; LIVER PROTECTIVE AGENT; MESSENGER RNA; MGN 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEPATITIS; LIVER INJURY; LIVER PROTECTION; MALE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RICE BRAN;

ANIMALS; ANTIGENS, CD14; CASPASE 1; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; ORYZA SATIVA; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; XYLANS;

EID: 84868594330     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.10.012     Document Type: Article

References (57)

1. M. Bozza, J.L. Bliss, R. Maylor, J. Erickson, L. Donnelly, and P. Bouchard Interleukin-11 reduces T-cell-dependent experimental liver injury in mice Hepatology 30 1999 1441 1447
2. G. Nunnari, and M.J. Schnell MicroRNA-122: a therapeutic target for hepatitis C virus (HCV) infection Front Biosci (Schol Ed) 3 2011 1032 1037
3. J. Lupberger, M.B. Zeisel, F. Xiao, C. Thumann, I. Fofana, and L. Zona EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy Nat Med 17 2011 589 595
4. D. Keppler, R. Lesch, W. Reutter, and K. Decker Experimental hepatitis induced by D-galactosamine Exp Mol Pathol 9 1968 279 290
5. K. Decker, and D. Keppler Galactosamine induced liver injury Prog Liver Dis 4 1972 183 199
6. K. Decker, and D. Keppler Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death Rev Physiol Biochem Pharmacol 71 1974 77 106
7. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamine-induced sensitization to the lethal effects of endotoxin Proc Natl Acad Sci U S A 76 1979 5939 5943
8. R.T. Stachlewitz, V. Seabra, B. Bradford, C.A. Bradham, I. Rusyn, and D. Germolec Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells Hepatology 29 1999 737 745
9. M. Ghoneum Biochem Biophys Res Commun 243 1998 25 29
10. M. Ghoneum Int J Immunotherapy 14 1998 89 99
11. M. Ghoneum, and S. Gollapudi Cancer Lett 201 2003 41 49
12. S. Zheng, H. Sanada, H. Dohi, S. Hirai, and Y. Egashira Suppressive effect of modified arabinoxylan from rice bran (MGN-3) on D-galactosamine- induced IL-18 expression and hepatitis in rats Biosci Biotechnol Biochem 76 2012 942 946
13. S. Lebel-Binay, A. Berger, F. Zinzindohoue, P. Cugnenc, N. Thiounn, and W.H. Fridman Interleukin-18: biological properties and clinical implications Eur Cytokine Netw 11 2000 15 26
14. F. Bauernfeind, A. Ablasser, E. Bartok, S. Kim, J. Schmid-Burgk, and T. Cavlar Inflammasomes: current understanding and open questions Cell Mol Life Sci 68 2011 765 783
15. F.L. Van de Veerdonk, M.G. Netea, C.A. Dinarello, and L.A. Joosten Inflammasome activation and IL-1β and IL-18 processing during infection Trends Immunol 32 2011 110 116
16. S. Alboni, D. Cervia, S. Sugama, and B. Conti Interleukin 18 in the CNS J Neuroinflammation 7 2010 9
17. H. Tsutsui, K. Adachi, E. Seki, and K. Nakanishi Cytokine-induced inflammatory liver injuries Curr Mol Med 3 2003 545 559
18. R.F. Schwabe, E. Seki, and D.A. Brenner Toll-like receptor signaling in the liver Gastroenterology 130 2006 1886 1900
19. S. Akira, and H. Hemmi Recognition of pathogen-associated molecular patterns by TLR family Immunol Lett 85 2003 85 95
20. Y. Peng, J.P. Gong, C.A. Liu, X.H. Li, L. Gan, and S.B. Li Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft World J Gastroenterol 10 2004 2890 2893
21. G.L. Su Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation Am J Physiol Gastrointest Liver Physiol 283 2002 256 265
22. Y.M. Kim, J.Y. Im, S.H. Han, H.S. Kang, and I. Choi IFN-gamma up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages J Immunol 165 2000 3198 3205
23. N. Arulkmaran, R.J. Unwin, and F.W.K. Tam A potential therapeutic role foe P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases Expert Opin Investig Drugs 20 2011 897 915
24. M. Kobayashi, I. Takeyoshi, D. Yoshinari, K. Matsumoto, and Y. Morishita P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver Surgery 131 2002 344
25. L.B. Seeff, K.L. Lindsay, B.R. Bacon, T.F. Kresina, and J.H. Hoofnagle Complementary and alternative medicine in chronic liver disease Hepatology 34 2001 595 603
26. H. Taniguchi, E. Yomota, K. Nogi, and Y. Onoda Effects of antiulcer agents on ethanol-induced gastric mucosal lesions in d-GalN-induced hepatitis rats Drug Res 52 2004 600 604
27. Y. Endo, T. Kikuchi, and M. Nakamura Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1or tumor necrosis factor by d-galactosamine Br J Pharmacol 107 1992 888 894
28. H. Maeda Production of modified arabinoxylan from rice bran (BioBran/MGN-3) 2006 Daiwa Pharmaceutical Co., Ltd.
29. D.S. Camara, J.A. Caruana Jr., K.A. Schwartz, M. Montes, and J.P. Nolan D-Galactosamine liver injury: absorption of endotoxin and protective effect of small bowel and colon resection in rabbits Proc Soc Exp Biol Med 172 1983 255 259
30. M.J. Czaja, J. Xu, Y. Ju, E. Alt, and P. Schmiedeberg Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration Hepatology 19 1994 282 289
31. S. Sakaguchi, S. Furusawa, K. Yokota, K. Sasaki, M. Takayanagi, and Y. Takayanagi Role of endogenous endotoxin on tumor necrosis factor- hypersensitivity caused by d-galactosamine challenge Biol Pharm Bull 23 2000 116 118
32. J.M. Alcorn, J. Fierer, and M. Chojkier The acute-phase response protects mice from d-galactosamine sensitization to endotoxin and tumor necrosis factor-alpha Hepatology 15 1992 122 129
33. H. Tsutsui, K. Matsui, H. Okamura, and H. Nakanishi Pathophysiological roles of interleukin-18 in inflammatory liver diseases Immunology 174 2000 192 209
34. T. Tanaka, H. Tsutsui, T. Yoshimoto, M. Kotani, M. Matsumoto, and A. Fujita Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga Int Arch Allergy Immunol 125 2001 236 240
35. K.S. Lee, S.R. Kim, S.J. Park, K.H. Min, K.Y. Lee, and S.M. Jin Antioxidant down-regulates interleukin-18 expression in asthma Mol Pharmacol 70 2006 1184 1193
36. S. Finotto, J. Siebler, M. Hausding, M. Schipp, S. Wirtz, and S. Klein Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo Gut 53 2004 392 400
37. L. Spahr, I. Garcia, S. Bresson-Hadni, L. Rubbia-Brandt, R. Guler, and M. Olleros Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis Liver Int 24 2004 582 587
38. K. Murata, N. Yamamoto, T. Kawakita, Y. Saito, Y. Yamanaka, and K. Sugimoto Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C Hepatogastroenterology 52 2005 547 551
39. J. Vecchiet, K. Falasca, P. Cacciatore, P. Zingariello, M. Dalessandro, and M. Marinopiccoli Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease Ann Clin Lab Sci 35 2005 415 422
40. G. Fantuzzi, and C.A. Dinarello Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1) J Clin Immunol 19 1999 1 11
41. Y. Gu, K. Kuida, H. Tsutsui, G. Ku, K. Hsiao, and M.A. Fleming Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme Science 275 1997 206 209
42. T. Ghayur, S. Banerjee, M. Hugunin, D. Butler, L. Herzog, and A. Carter Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production Nature 386 1997 619 623
43. H. Tsutsui, N. Kawagaki, K. Kuida, H. Nakano, N. Hayashi, and K. Takeda Caspase-1 independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice Immunity 11 1999 359 367
44. M.J. Sweet, and D.A. Hume Endotoxin signal transduction in macrophages J Leukoc Biol 60 1996 8 26
45. K. Suk, S.Y. Kim, and H. Kim Regulation of IL-18 production by IFN gamma and PGE2 in mouse microglial cells: involvement of NFκB pathway in the regulatory processes Immunol Lett 77 2001 79 85
46. B.R. Lin, C.J. Yu, W.C. Chen, H.S. Lee, H.M. Chang, and Y.C. Lee Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling J Biomed Sci 16 2009 35
47. H. Nishioka, T. Kishioka, C. Iida, K. Fujii, I. Ichi, and S. Kojo Activation of mitogen activated protein kinase (MAPK) during D-galactosamine intoxication in the rat liver Bioorg Med Chem Lett 11 2006 3019 3022
48. Y. Wang, C. Li, X. Wang, J. Zhang, and Z. Chang Heat shock response inhibits IL-18 expression through the JNK pathway in murine peritoneal macrophages Biochem Biophys Res Commun 23 2002 742 748
49. B.M. Thobe, M. Frink, F. Hilderbrand, M. Schwacha, M.J. Hubbard, and M.J. Choudhry The role of MAPK in Kupffer cell Toll-like receptor (TLR) 2-, TLR4- and TLR9-mediated signaling following trauma-hemorrhage J Cell Physiol 210 2007 667 675
50. T. Takayashiki, H. Yoshidome, F. Kimura, M. Ohtsuka, Y. Shimizu, and A. Kato Increased expression of toll-like receptor 4 enhances endotoxin-induced hepatic failure in partially hepatectomized mice J Hepatol 41 2004 621 628
51. S. Zhai, R.K. Hansen, R. Taylor, J.N. Skepper, R. Sanches, and N.K.H. Slater Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization Biotechnol Prog 20 2004 1113 1120
52. T. Gustot, A. Lemmers, C. Moreno, N. Nagy, E. Quertinmont, and C. Nicaise Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver Hepatology 43 2006 989 1000
53. S. Inokuchi, H. Tsukamoto, E. Park, Z.X. Liu, D.A. Brenner, and E. Seki Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice Alcohol Clin Exp Res 35 2011 1509 1518
54. A. Haziot, E. Ferrero, X.Y. Lin, C.L. Stewart, and S.M. Goyert CD14-deficient mice are exquisitely insensitive to the effects of LPS Prog Clin Biol Res 392 1995 351
55. A. Haziot, E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, and J. Silver Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice Immunity 4 1996 407
56. H.A. Jarvelainen, A. Orpana, M. Perola, V.T. Savolainen, P.J. Karhunen, and K.O. Lindros Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease Hepatology 33 2001 1148 1153
57. M. Yin, B.U. Bradford, M.D. Wheeler, T. Uesugi, M. Froh, and S.M. Goyert Reduced early alcohol-induced liver injury in CD14-deficient mice J Immunol 166 2001 4737 4742